TickerFactsScreenerDevelopers

Spero Therapeutics, Inc. (SPRO) — Operating Income

Annual figures by fiscal year, from SEC filings.

2015: -$13.33M2016: -$33.22M2017: -$41.73M2018: -$42.81M2019: -$63.22M2020: -$79.11M2021: -$87.97M2022: -$42.20M2023: $21.48M2024: -$73.36M2025: $6.31M$6.31M
2015Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$6.31M+108.6%
2024-$73.36M-441.5%
2023$21.48M+150.9%
2022-$42.20M+52.0%
2021-$87.97M-11.2%
2020-$79.11M-25.1%
2019-$63.22M-47.7%
2018-$42.81M-2.6%
2017-$41.73M-25.6%
2016-$33.22M-149.3%
2015-$13.33M—